Covered recipient · General Payments record
GREGORY K HUTTEGER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,591.88
- Reported across 175 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $293.62 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $92.03 | 5 |
| ABBVIE INC. | $70.56 | 3 |
| SANOFI-AVENTIS U.S. LLC | $43.31 | 2 |
| Abbott Laboratories | $23.94 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.44 | 1 |
| Exact Sciences Corporation | $15.40 | 1 |
| Acerta Pharma LLC | $14.43 | 1 |
| Astellas Pharma US Inc | $13.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.94 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125379544 | CMS |
| ABBVIE INC. | $16.34 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960335 | CMS |
| ABBVIE INC. | $26.85 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960337 | CMS |
| ABBVIE INC. | $27.37 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960339 | CMS |
| Astellas Pharma US Inc | $13.51 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139366733 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.43 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104655135 | CMS |
| Boston Scientific Corporation | $20.44 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092580609 | CMS |
| Exact Sciences Corporation | $15.40 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114712053 | CMS |
| Novo Nordisk Inc | $21.06 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096579065 | CMS |
| Novo Nordisk Inc | $17.04 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097723638 | CMS |
| Novo Nordisk Inc | $13.59 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097345420 | CMS |
| Novo Nordisk Inc | $20.84 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096725828 | CMS |
| Novo Nordisk Inc | $19.50 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096899434 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.55 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139733772 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.76 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139733996 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.